Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM50239947 (CHEMBL4089730 | US20230303494, Compound BMS202 | U...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365922 (4-{[({2,6-dimethoxy-4- [(2-methyl-3-phenylphenyl) ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365862 ((3S)-4-{[(4-{[3-(2,3-dihydro-1,4- benzodioxin-6-yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 43 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365876 (2-[3,5-dimethoxy-4-(morpholin- 4-ylmethyl)phenoxym...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365885 (2-[3,5-dimethoxy-4-({[3-(2- oxopyrrolidin-1- yl)pr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365889 (2-(3,5-dimethoxy-4-{[(2- methoxyethyl)amino]methyl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365892 (2-(4-{[(4- hydroxycyclohcxyl)amino] methyl}-3,5- d...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365894 (2-{3,5-dimethoxy-4- [(methylamino)methyl] phenoxym...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365897 (2-{4-[(4-acetylpiperazin-1- yl)methyl]-3,5- dimeth...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365906 (2-{4-[(3-hydroxypiperidin-1- yl)methyl]-3,5- dimet...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365933 (2-(2-{2-[({2,6-dimethoxy-4-[(2- methyl-3- phenylph...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365934 ((2S)-5-[({2,6-dimethoxy-4-[(2- methyl-3- phenylphe...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365984 (1-[({2,6-dimethoxy-4-[(2- methyl-3- phenylphenyl)m...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365985 (US9872852, Example 237 | {1-[({2,6-dimethoxy-4-[(2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365998 (3-[({2,6-dimethoxy-4- [(2-methyl-3- phenylphenyl)m...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM366000 ((2R)-2-[({2,6-dimethoxy-4-[(2- methyl-3- phenylphe...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM366027 ((2S,3R)-2-[({2,6-dimethoxy-4- [(2-methyl-3- phenyl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365372 ((S)-1-(2,6-dimethoxy-4-((2-methylbiphenyl-3-yl)met...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365754 (({2,6-dimethoxy-4-[(2-methyl-3- phenylphenyl)metho...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365826 ((2S)-2-[({3-chloro-4-[(2-methyl-3- phenylphenyl)me...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365860 ((2S)-1-[(4-{[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365896 (2-{3,5-dimethoxy-4-[(2- methylpyrrolidin-1- yl)met...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365898 (2-[3,5-dimethoxy-4-(pyrrolidin-1- ylmethyl)phenoxy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365899 (2-(4-{[3-(hydroxymethyl) piperidin-1-yl]methyl}-3,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365902 (2-{4-[(4-acetyl-1,4-diazepan-1- yl)methyl]-3,5- di...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365909 ((2S)-1-({4-[(2-cyano-3- phenylphenyl)methoxy]-2,6-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365926 (4-[({2,6-dimethoxy-4-[(2-methyl- 3-phenylphenyl)me...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365990 ((2S)-2-[({2,6-dimethoxy-4-[(2- methyl-3- phenylphe...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365996 (1-[({2,6-dimethoxy-4- [(2-methyl-3- phenylphenyl)m...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM366005 (1-[({2,6-dimethoxy-4- [(2-methyl-3- phenylphenyl)m...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM366006 (({2,6-dimethoxy-4-[(2-methyl-3- phenylphenyl)metho...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM366017 ((2S)-2-cyclohexyl-2-[({2,6- dimethoxy-4-[(2-methyl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM366019 (2-[({2,6-dimethoxy-4- [(2-methyl-3- phenylphenyl)m...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM366031 ((2S)-2-[({2,6-dimethoxy-4-[(2- methyl-3- phenylphe...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM366039 (US9872852, Example 291 | [(4-{[3-(2,3-dihydro-1,4-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM50239942 (CHEMBL4081869 | US9872852, Example 37) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365851 (2-[({2,6-dimethoxy-4-[(2-methyl- 3-phenylphenyl) m...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365858 (4-{[({3-methyl-4-[(2-methyl-3- phenylphenyl)methox...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365859 ((3S)-4-[({2,6-dimethoxy-4-[(2- methyl-3-phenylphen...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365882 (2-{4-[(cyclobutylamino)methyl]- 3,5-dimethoxypheno...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365884 (2-{4-[(cyclohexylamino)methyl]- 3,5-dimethoxypheno...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365887 (N-{2-[({4-[(2-cyano-3- phenylphenyl)methoxy]-2,6- ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365893 (3-[({4-[(2-cyano-3- phenylphenyl)methoxy]-2,6- dim...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365929 (1-{2,6-dimethoxy-4-[(2-methyl- 3-phenylphenyl)meth...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM50239944 (CHEMBL4061613 | US9872852, Example 241) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM366001 ((2S)-1-[({2,6-dimethoxy-4-[(2- methyl-3- phenylphe...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM366003 ((1S,2R)-2-[({2,6-dimethoxy-4- [(2-methyl-3- phenyl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM366015 (2-[({2,6-dimethoxy-4- [(2-methyl-3- phenylphenyl)m...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM366043 ((3S)-4-[({4-[(2-cyano-3- phenylphenyl)methoxy]-2,6...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Programmed cell death 1 ligand 1 (Homo sapiens (Human)) | BDBM365801 (1-({3-methyl-4-[(2-methyl-3- phenylphenyl)methoxy]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharmaceuticals | Assay Description All binding studies were performed in an HTRF assay buffer consisting of dPBS supplemented with 0.1% (withv) bovine serum albumin and 0.05% (v/v) Twe... | J Med Chem 51: 4-16 (2008) BindingDB Entry DOI: 10.7270/Q2RN3B42 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 297 total ) | Next | Last >> |